文献速递关节外科创伤骨科

脂质体布比卡因与罗哌卡因用于全膝关节置换术收肌管阻滞的随机对照试验

Liposomal Bupivacaine vs Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty: A Prospective Randomized Trial.
PubMed 文献 · J Arthroplasty · 2021-08-21

结果显示两组在疼痛评分、口服阿片类药物总消耗量(MME)、住院时长及关节疼痛僵硬评分等所有测量结局上均无统计学显著差异,不支持脂质体布比卡因优于罗哌卡因。

要点

  • 两组在疼痛、MME、住院时长及KOOS-JR与总体镇痛获益评分上均无统计学显著差异。
  • 研究未发现脂质体布比卡因较罗哌卡因增加术后镇痛获益的证据。

核心结论

  • 研究未发现脂质体布比卡因较罗哌卡因在全膝关节置换术后提供更多镇痛获益的证据。

研究设计与样本

  • 试验组收肌管阻滞使用脂质体布比卡因与布比卡因混合液,对照组使用罗哌卡因,仅实施阻滞的麻醉医师知晓分组。
  • 术后24、48、72小时根据患者出院状态面对面或电话记录MME、疼痛评分、KOOS-JR及总体镇痛获益评分。

主要发现

  • 主要结局为数字评分量表疼痛、MME及住院时长(小时),两组间均无统计学显著差异。
  • 次要结局为以KOOS-JR记录的关节疼痛与僵硬及总体镇痛获益评分,两组间亦无统计学显著差异。

临床怎么用

  • 在全膝关节置换术收肌管阻滞中,选择脂质体布比卡因联合布比卡因或罗哌卡因时,本研究未显示前者在镇痛、阿片消耗或住院时长上的额外优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study is to determine the benefit of the analgesic liposomal bupivacaine compared to ropivacaine, by assessing pain and joint stiffness, and total oral opioid consumption by milligram morphine equivalent (MME) after total knee arthroplasty. METHODS: Patients were randomized to receive either the study drug (liposomal bupivacaine admixed with bupivacaine) or the control drug (ropivacaine) in an adductor canal block. Only the anesthesiologist performing the block was aware of which arm of the study the patient was randomized to. MME, pain, Knee injury and Osteoarthritis Outcome Score Joint Replacement, and overall benefit of analgesia scores were recorded 24, 48, and 72 hours post-surgery either face-to-face or via telephone depending on patient discharge status. RESULTS: One hundred patients were enrolled into the study and analyzed: 54 in the control group and 46 in the experimental group. Primary outcomes measured were pain as a numerical rating scale, MME, and length of stay in hours. Secondary outcomes were joint pain and stiffness recorded as Knee injury and Osteoarthritis Outcome Score Joint Replacement outcome and overall benefit of analgesia score. No statistically significant between-group differences were observed for any measured outcome. CONCLUSION: We did not find any supporting evidence that liposomal bupivacaine yields increased pain relief following total knee arthroplasty compared to the control drug, ropivacaine.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hungerford M, Neubauer P, Ciotola J, et al. Liposomal Bupivacaine vs Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty: A Prospective Randomized Trial. J Arthroplasty. 2021. PMID: 34556382. doi:10.1016/j.arth.2021.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。